Physician profile
Amy Miskiewicz
NPI 1265013429
$1,380.66
in general payments reported to CMS, 2019-2025
16 companies · $642 in 2025
The $642 reported for 2025 was more than what 77% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $369 · 2024: $370 · 2025: $642.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,012.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,012.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $378.22 | 2021-2025 | Tavneos |
| Bayer Healthcare Pharmaceuticals INC. | $162.76 | 2021-2024 | |
| Avadel Cns Pharmaceuticals, LLC | $125.00 | 2025 | Lumryz |
| Gilead Sciences, INC. | $125.00 | 2024 | Descovy |
| Dexcom, INC. | $115.78 | 2025 | Dexcom Stelo Glucose Biosensor, Dexcom G7 Gss (161) |
| Phathom Pharmaceuticals, INC. | $101.28 | 2025 | Voquezna |
| Mallinckrodt Hospital Products INC. | $100.00 | 2025 | Acthar |
| Lilly USA, LLC | $99.18 | 2025 | Zepbound |
| Janssen Pharmaceuticals, INC | $40.51 | 2021 | |
| Merck Sharp & Dohme LLC | $27.54 | 2021 | |
| Paratek Pharmaceuticals, INC. | $23.95 | 2021 | |
| Genentech USA, INC. | $22.51 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $18.36 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $16.17 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $13.09 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $11.31 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Miskiewicz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.